SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Robohogs who wrote (9988)3/26/2007 10:41:43 PM
From: Iamarangerboy   of 10280
 
Take this pill and shove it!
Drug sales representatives say they are increasingly disillusioned amid signs of industry cutbacks and tougher government regulations.

money.cnn.com

ATLANTIC CITY, N.J. (CNNMoney.com) -- Big Pharma, already reeling from mounting competition and tightening government regulations, now has another problem to deal with: an oversupply of sales reps, many of whom are fed up with what they describe as an increasingly restrictive work environment, according to drug industry officials.......
As a result, sales teams are paying a hefty price. Pfizer (Charts), the world's biggest drug company, announced in January plans to lay off 10,000 sales reps. The downsizing came one month after the company ceased trials on the anti-cholesterol drug torcetrapib, once considered a potential blockbuster.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext